A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 11, 2008, Pages 1071-1078

  Velasco, E ^a,b   Bigni, R ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Hospital Do Câncer Unidade I ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANDIDEMIA; CHILD; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; FEMALE; FUNGEMIA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 55549106788     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0546-y     Document Type: Article

References (29)

1. H Wisplinghoff T Bischoff SM Tallent H Seifert RP Wenzel MB Edmond 2004 Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 309 317
2. E Velasco R Byington CAS Martins M Schirmer LCM Dias VMSC Gonçalves 2004 Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects Clin Microbiol Infect 10 542 549
3. AM Rentz MT Halpern R Bowden 1998 The impact of candidemia on length of hospital stay, outcome, and overall cost of illness Clin Infect Dis 27 781 788
4. B Almirante D Rodríguez BJ Park M Cuenca-Estrella AM Planes M Almela J Mensa F Sanchez J Ayats M Gimenez P Saballs SK Fridkin J Morgan JL Rodriguez-Tudela DW Warnock A Pahissa Barcelona Candidemia Project Study Group 2005 Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 J Clin Microbiol 43 1829 1835
5. PG Pappas JH Rex J Lee RJ Hamill RA Larsen W Powderly CA Kauffman N Hyslop JE Mangino S Chapman HW Horowitz JE Edwards WE Dismukes NIAID Mycoses Study Group 2003 A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients Clin Infect Dis 37 634 643
6. TE Zaoutis J Argon J Chu JÁ Berlin TJ Walsh C Feudtner 2005 The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis Clin Infect Dis 41 1232 1239
7. O Marchetti J Bille U Fluckiger P Eggimann C Ruef J Garbino T Calandra MP Glauser MG Täuber D Pittet Fungal Infection Network of Switzerland (FUNGINOS) 2004 Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000 Clin Infect Dis 38 311 320
8. C Viscoli C Girmenia A Marinus L Collette P Martino B Vandercam C Doyen B Lebeau D Spence V Krcmery B De Pauw F Meunier 1999 Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC) Clin Infect Dis 28 1071 1079
9. H Alonso-Valle O Acha JD García-Palomo C Fariñas- Álvarez C Fernández-Mazarrasa MC Fariñas 2003 Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality Eur J Clin Microbiol Infect Dis 22 254 257
10. TE Zaoutis HM Greeves E Lautenbach WB Bilker SE Coffin 2004 Risk factors for disseminated candidiasis in children with candidemia Pediatr Infect Dis J 23 635 641
11. H Paganini T Rodriguez Brieshcke P Santos S Seú MT Rosanova 2002 Risk factors for nosocomial candidaemia: a case-control study in children J Hosp Infect 50 304 308
12. Karnofsky DA, Burchenot JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLead CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191-205
13. World Health Organization (WHO) (1979) Handbook for reporting results of cancer treatment. WHO, Geneva
14. AS Johnston JF Piccirillo C Creech B Littenberg D Jeffe EL Spitznagel 2001 Validation of a comorbidity education program J Reg Manage 28 125 131
15. JS Garner WR Jarvis TG Emori TC Horan JM Hughes 1988 CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 128 140
16. AC Pasqualotto WL Nedel TS Machado LC Severo 2005 A 9-year study comparing risk factors and the outcome of paediatrics and adults with nosocomial candidaemia Mycopathol 160 111 116
17. AL Colombo M Nucci BJ Park SA Nouér B Arthington-Skaggs DA da Matta D Warnock J Morgan Brazilian Network Candidemia Study 2006 Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers J Clin Microbiol 44 2816 2823
18. AL Colombo T Guimarães LRBF Silva LP de Almeida Monfardini AK Cunha P Rady T Alves RC Rosas 2007 Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality Infect Control Hosp Epidemiol 28 570 576
19. ND Friedman KS Kaye JE Stout SA McGarry SL Trivette JP Briggs W Lamm C Clark J MacFarquhar AL Walton LB Reller DJ Sexton 2002 Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 791 797
20. O Gudlaugsson S Gillepie K Lee J Vande Berg J Hu S Messer L Herwaldt M Pfaller D Diekema 2003 Attributable mortality of nosocomial candidemia, revisited Clin Infect Dis 37 1172 1177
21. A Viudes J Pemán E Cantón P Úbeda JL López-Ribot M Gobernado 2002 Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death Eur J Clin Microbiol Infect Dis 21 767 774
22. V Silva MC Díaz N Febré Chilean Invasive Fungal Infections Group 2004 Invasive fungal infections in Chile: a multicenter study of fungal prevalence and susceptibility during a 1-year period Med Mycol 42 333 339
23. AL Colombo M Nucci R Salomão ML Branchini R Richtmann A Derossi SB Way 1999 High rate of non-albicans candidemia in Brazilian tertiary care hospitals Diagn Microbiol Infect Dis 34 281 286
24. C Girmenia P Martino F De Bernardis G Gentile M Boccanera M Monaco G Antonucci A Cassone 1996 Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains Clin Infect Dis 23 506 514
25. EJ Anaissie JH Rex O Uzun S Vartivarian 1998 Predictors of adverse outcome in cancer patients with candidemia Am J Med 104 238 245
26. M Nucci MIS Silveira N Spector F Silveira E Velasco T Akiti G Barreiros A Derossi AL Colombo W Pulcheri 1998 Risk factors for death among cancer patients with fungemia Clin Infect Dis 27 107 111
27. JF Piccirillo AR Feinstein 1996 Clinical symptoms and comorbidity: significance for the prognostic classification of cancer Cancer 77 834 842
28. JF Piccirillo RM Tierney I Costas L Grove EL Spitznagel Jr 2004 Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 2441 2447
29. WL Read RM Tierney NC Page I Costas R Govindan EL Spitznagel JF Piccirillo 2004 Differential prognostic impact of comorbidity J Clin Oncol 22 3099 3103